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Exposure of mesothelial cells to asbestos fibers in vitro has been shown to induce DNA damage
mediated by oxidants. An early cellular response to DNA damage is increased expression of the
p53 protein. This protein induces transcription of genes that activate cell cycle checkpoints or
induce apoptosis. A murine mesothelial cell line that spontaneously acquired a point mutation in
the p53 gene shows increased sensitivity to DNA damage induced by crocidolite asbestos fibers.
It is hypothesized that p53-deficient mice will show increased sensitivity to the genotoxic effects
of asbestos and accelerated development of malignant mesotheliomas. Environ Health
Perspect 105(Suppl 5):1069-1072 (1997)
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Introduction
Diffuse malignant mesothelioma is a lethal
neoplasm arising from the pleura, peri-
toneum, or pericardium. Most cases of
mesothelioma are associated with a history
ofoccupational exposure to asbestos; cases
occurring after household or neighborhood
exposure have also been reported (1).
Asbestos fibers are classified in two cate-
gories: serpentine or chrysotile asbestos and
amphiboles. Chrysotile consists ofcurly,
white fibers and accounts for 90 to 95% of
asbestos used commercially. Amphiboles
are long, straight fibers and include croci-
dolite, amosite, anthophyllite, and tremo-
lite. Although tremolite is not used
commercially, this amphibole is a common
contaminant of some deposits of sand,
talc, and chrysotile asbestos. Malignant
mesothelioma has also been associated with
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environmental exposure to tremolite
asbestos or to erionite (2).
The mechanisms leading to the devel-
opment of malignant mesothelioma are
unknown. It is hypothesized that fiber
geometry and dimensions, chemical com-
position, surface reactivity, and biopersis-
tence in the lungs are important parameters
related to toxicity (3). Asbestos fibers gen-
erate reactive oxygen species in a variety of
cell-free assays [reviewed by Moyer et al.
(4)]. Macrophages exposed to asbestos
fibers in vitro release reactive oxygen (5)
and nitrogen species (6). The availability of
iron at the surface offibers is a critical para-
meter in catalyzing the generation ofthese
highly reactive oxygen and nitrogen radicals
(7). Ferric and ferrous cations are major
components ofamphibole asbestos fibers;
iron may also be present as surface impuri-
ties on serpentine asbestos or some man-
made fibers. Asbestos and other mineral
fibers such as erionite may release or acquire
iron from the surrounding medium,
depending on the presence ofchelators or
reducing agents (8).
Several investigators have obtained
evidence that reactive oxygen and nitrogen
species contribute to DNA damage induced
by asbestos fibers using a variety oftarget
cell populations in vitro. Exogenous catalase
or superoxide dismutase prevented DNA
damage induced by asbestos in rat pleural
mesothelial cells (9) or a human-hamster
hybrid cell line (10). Crocidolite asbestos
fibers induced formation ofmicronuclei in
murine peritoneal mesothelial cells (11);
this damage was also prevented by exoge-
nous scavenging enzymes. Both reactive
nitrogen intermediates and iron contribute
to DNA damage induced by asbestos fibers
in ahuman lung carcinoma cell line (12).
DNA breaks induced by oxidants,
ionizing radiation, and chemotherapeutic
drugs trigger a sequence ofresponses that
arrest cells in the G1 phase ofthe cell cycle
or induce apoptosis (13). A key event lead-
ing to these responses is increased expres-
sion of the p53 protein, followed by
expression ofadditional genes that mediate
cell cycle arrest or apoptosis. Cells lacking
functional p53 protein as a result ofgene
deletion, formation ofcomplexes with viral
proteins, or point mutation are defective in
cell cycle arrest or apoptosis triggered by
DNA-damaging agents (14). Cistulli et al.
(11) have shown that a murine mesothelial
cell line that spontaneously acquired a point
mutation in thep53 gene has increased sus-
ceptibility to induction ofmicronuclei by
exposure to ionizing radiation or crocidolite
asbestos fibers in vitro.
Several strains of transgenic mice have
been developed that carry one or two copies
ofa disrupted p53 allele (15). These mice
show increased susceptibility to induction
ofmicronuclei and tumors by ionizing radi-
ation (16). Preliminary studies indicate
that p53-deficient mice show increased
micronuclei in proliferating mesothelial
cells after ip injection ofcrocidolite asbestos
fibers. Therefore, we hypothesize that p53-
deficient mice will show increased suscepti-
bility to induction of mesotheliomas by
asbestos fibers.
Methods
In VivoStudies
Homozygous (-/-), heterozygous (+/-),
and wild-type (+/+) mice derived from the
129/Sv strain (17) were purchased from
Jackson Laboratories (Bar Harbor, ME).
Groups of 10 to 30 mice 6 to 8 weeks of
age were injected weekly with 200 pg
(5.8x 108 fibers) of Union Internationale
Contre le Cancer (UICC) crocidolite
asbestos suspended in 1.0 ml saline for 35
weeks. Mice were sacrificed as they devel-
oped ascites or weight loss. All experiments
were conducted according to the guidelines
established by the National Institutes of
Health Guide for the Care and Use of
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Laboratory Animals. Histologic sections of
all abdominal and thoracic organs were
examined for the presence oftumors using
the criteria described by Davis et al. (18).
Malignant mesotheliomas were confirmed
by expression ofcytokeratins as evaluated
by immunohistochemistry (19).
In VitroStudies
Primary murine mesothelial cells were
isolated from peritoneal lavage fluid or fol-
lowing trypsinization of the peritoneal
cavity as described previously (11). Wild-
type (+/+) and homozygous p53-deficient
(-/-) mesothelial cells were maintained for
4 to 16 passages in vitro. Growth curves
were generated as described previously
(11). Preparation ofmetaphase spreads was
carried out as described previously (20).
Apoptosis was induced inwild-type and
p53-deficient murine mesothelial cells by
exposure to crocidolite asbestos (7.5 jig/cm2)
(21) or camptothecin (10 pg/ml) for 24 hr.
Two assays for induction ofapoptosis were
used. DNA breaks with exposed 3'-OH
ends were lab-eled by incorporation of
biotinylated dUTP catalyzed by TdT;
dUTP incorporation was detected by
avidin-peroxidase immunohistochemistry
using a kit purchased from Oncor, Inc.
(Gaithersburg, MD). This assay was con-
firmed by agarose gel electrophoresis oflow
molecular weight DNA isolated from con-
trol and treated mesothelial cells. After
ethidium bromide staining, a characteristic
DNA ladder at 180-bp intervals was seen
in apoptotic cells (22).
Results and Discussion
InductionofMesotheliomas in
p53-deficientMice
After 22 weekly ip injections, 12.5% ofthe
homozygous p53-deficient mice developed
mesotheliomas. The remainder of this
cohort died with thymic lymphomas or
hemangiosarcomas that develop sponta-
neously inp53-/- mice (23). After a mean
latency of44 weeks, 76% ofthe heterozy-
gous p53-deficient mice developed meso-
theliomas compared to 32% ofwild-type
mice (Table 1). No spontaneous develop-
ment ofmesotheliomas has been observed
in these genetically engineered mouse
strains (23).
Accelerated development of malignant
mesothelioma induced by asbestos fibers in
p53-deficient mice could be explained by
three mechanisms. First, p53-deficient
mesothelial cells could have a selective
growth advantage overwild-type cells (24).
Second, p53-deficient mesothelial cells
could have increased genetic instability sec-
ondary to loss ofG1 arrest and incomplete
repair of DNA damage (17). Genetic
instability would predispose p53-deficient
cell populations to acquisition of addi-
tional mutations or deletions in cell cycle
regulatory genes or tumor suppressor
genes. Finally, p53-deficient mesothelial
cells may be resistant to apoptosis (25).
These mechanisms were explored in vitro.
Table 1. Incidence of malignant mesotheliomas in
p53-deficient mice
p53Genotype
* ~~-I- +/- +1+
Fraction of mice 1/8 13/17 9/28
with tumorsa (12.5%) (76%) (32%)
Latency, weeks 10 44 ± 2b 67 ± 1 c
"The incidences of tumors and the genotypes are not
independent; p = 0.003 using Fisher's exact test.
bMean ± SEM. cThe mean latency between heterozy-
gous +/- and wild-type +/+ mice is statistically signifi-
cant; p= 0.002 using Fisher's PLSD test.
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GrowthandApoptosis of
p53-deficientandWild-type
Mesothdial Cells in Vitro
Growth ofearly passage p53 +1+ and -I-
murine peritoneal mesothelial cells was
compared in vitro. The doubling time of
p53 +/+ cells was approximately 24 hr,
compared to only 12 hr for p53 -/- cells
(Figure 1). The p53 +/+ cells were nearly
diploid with a mean chromosome number
of41 ± 7, while p53 -/- cells were nearly
tetraploid with a mean chromosome num-
ber of72 ± 6 (Figure 2). This observation is
consistent with loss ofa spindle checkpoint
inp53-deficient cells (26).
Induction of apoptosis by ionizing
radiation and chemotherapeutic drugs is
p53 dependent (14). Early passagep53 +1+
mesothelial cells treated with crocidolite
asbestos or camptothecin for 24 hr showed
evidence ofapoptosis as indicated by dUTP
incorporation by TdT at 3'-OH ends of
DNA (Table 2) and appearance ofa DNA
ladder on agarose gels (data not shown). In
contrast, p53 -/- mesothelial cells were
resistant to induction ofapoptosis by expo-
sure to crocidolite asbestos or camptothecin
in vitro. Experiments are in progress to
Table 2. Induction of apoptosis by camptothecin in
wild-type and p53-deficient murine mesothelial cells in
vitro.
p53genotype
lI- +/+
Control 0 ± 0 0.45 ± 0.23a
Camptothecin 0.13± 0.13 12.2 ±2.7b
5 "apercent of cells positive for apoptosis using 3-OH 4 5
end labeling; mean ± SEM from three experiments.
bThe difference between homozygous -/- and wild-
+) and homo- type +/+ mesothelial cells is statistically significant;
lines in vitro. p= 0.002 using Fisher's PLSD test.
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Figure 2. Number of chromosomes determined on metaphase spreads of wild-type p53(+/+) and homozygous
deficientp53(-I-) mesothelial cell lines in vitro afterexposure to colcemid (0.2 pg/ml for 1.5 hr).
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assess whether p53-deficient mesothelial
cells showcomparable resistance to apoptosis
in viVo.
RelevanceofThisMurineModel to
Human MalinantMesotheioma
Point mutations and deletions in the p53
tumor suppressor gene are relatively rare
in human (27) and murine malignant
mesothelioma cell lines (28). Patients
with the Li-Fraumeni syndrome carry one
mutated p53 allele and have an increased
risk of developing sarcomas and brain,
bone, breast, and adrenal cancers. A recent
case-control study revealed a slightly
increased risk of mesothelioma in people
who were exposed to asbestos and had first
degree relatives with the Li-Fraumeni
syndrome (29). Despite infrequent point
mutations in the p53 gene, human malig-
nant mesotheliomas show overexpression
of the p53 protein (30-32). A possible
explanation for this paradoxical finding is
a recent report that SV40-like DNA
sequences and T-antigen have been identi-
fied in some human malignant mesothe-
liomas (33). Viral proteins such as SV40
Macrophages + asbestos
Oxidants
Resistance
to apoptosis
Mesothelial ' Proliferation , Genetic , Persistent proliferation - Neoplasia
cell injury damage genetic instability
Loss of cell cycle
checkpoints
Figure 3. Proposed mechanism for induction ofmalignant mesothelioma byasbestos fibers.
T-antigen bind to the p53 protein, prolong
its half-life, and inactivate its normal func-
tions (14). Human malignant mesothe-
liomas are frequently aneuploid and show
multiple cytogenetic abnormalities (34).
This observation is consistent with increased
genetic instability due to inactivation ofp53
and abrogation ofcell cycle checkpoints.
Figure 3 proposes the following
hypothesis: The initial response of the
mesothelial lining to asbestos fibers is injury
that is repaired by proliferation (35).
Production of oxidants by macrophages
attempting to phagocytize asbestos fibers
trapped at the mesothelial surface has been
demonstrated in situ (36). It is hypothe-
sized that macrophages release reactive oxy-
gen and nitrogen species that induce DNA
damage and apoptosis in mesothelial cells.
Abrogation ofp53 function by targeted
deletion (p53-deficient mice) or inactiva-
tion by viral proteins (?humans) results in
loss ofcell cycle checkpoints and resistance
to apoptosis in proliferating mesothelial
cells. Functional inactivation ofp53 or
other components of the GI cell cycle
checkpoint (32) would accelerate later
stages in the development and progression
of malignant mesotheliomas induced by
asbestos fibers.
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